Tag:Cellular Goods

In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting share price losses across...

CELLULAR Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to be sold in the UK.  At...

THE fallout from the publication of the FSA's Public List is continuing to be felt on the stock markets this week, with the regulator...

European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.  Mid-week...

FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history. 

The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears were realised on Thursday...

On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets. 

Cellular Goods today announces the release of a major new white paper, 'Cannabinoids for the Prevention of Aging', which explores the benefits cannabinoids, namely cannabidiol (CBD) and cannabigerol (CBG), can have for the skin by preventing the signs of aging.